T1	Temporal 0 12	simultaneous
T2	Qualifier 13 23	both sided
T3	Procedure 55 71	molar extraction
T4	Qualifier 38 54	only upper third
*	OR T2 T4
T5	Scope 13 54	both sided extraction or only upper third
R1	Has_scope Arg1:T3 Arg2:T5	
R2	Has_temporal Arg1:T3 Arg2:T1	
T6	Procedure 73 91	general anesthesia
T7	Condition 111 138	abnormal coagulation status
T8	Qualifier 102 110	presumed
T9	Qualifier 93 98	known
*	OR T9 T8
T10	Scope 93 110	known or presumed
R3	Has_scope Arg1:T7 Arg2:T10	
T11	Qualifier 140 145	known
T12	Qualifier 149 157	presumed
*	OR T11 T12
T13	Scope 140 157	known or presumed
T14	Condition 167 184	renal dysfunction
T15	Condition 158 163;173 184	liver dysfunction
*	OR T14 T15
T16	Scope 158 184	liver or renal dysfunction
R4	Has_scope Arg1:T16 Arg2:T13	
T17	Condition 186 202	contraindication
T18	Drug 211 221	metamizole
R5	AND Arg1:T17 Arg2:T18	
T19	Qualifier 222 227	known
T20	Qualifier 231 240	suspected
*	OR T19 T20
T21	Scope 222 240	known or suspected
T22	Qualifier 242 247	known
T23	Qualifier 251 260	suspected
T24	Condition 261 268	allergy
T25	Drug 277 285	novalgin
T26	Drug 295 306	pyrazolones
T27	Qualifier 289 294	other
R6	Has_qualifier Arg1:T26 Arg2:T27	
T28	Condition 308 329	anaphylactic reaction
T29	Drug 338 344	NSAIDS
T30	Measurement 356 376	bone marrow function
T31	Value 346 355	decreased
T32	Measurement 380 392	hematopoesis
*	OR T32 T30
T33	Scope 356 392	bone marrow function or hematopoesis
R7	Has_value Arg1:T33 Arg2:T31	
T34	Condition 394 411	hepatic porphyria
T35	Condition 413 457	glucose-6-phosphate dehydrogenase deficiency
T36	Condition 463 472	pregnancy
T37	Observation 473 486	breastfeeding
*	OR T36 T37 T35 T34 T33
R8	AND Arg1:T28 Arg2:T29	
*	OR T25 T26
T38	Scope 277 306	novalgin or other pyrazolones
R9	Has_scope Arg1:T24 Arg2:T38	
*	OR T23 T22
T39	Scope 242 260	known or suspected
R10	Has_scope Arg1:T24 Arg2:T39	
*	OR T24 T28
T40	Scope 242 486	known or suspected allergy against novalgin or other pyrazolones, anaphylactic reaction against NSAIDS, decreased bone marrow function or hematopoesis, hepatic porphyria, glucose-6-phosphate dehydrogenase deficiency, and pregnancy/breastfeeding
R11	Has_scope Arg1:T17 Arg2:T21	
T41	Scope 186 240	contraindication against metamizole known or suspected
R12	Subsumes Arg1:T41 Arg2:T40	
T42	Condition 489 505	contraindication
T43	Drug 514 523	ibuprofen
R13	AND Arg1:T42 Arg2:T43	
T44	Qualifier 525 530	known
T45	Qualifier 534 543	suspected
*	OR T44 T45
T46	Condition 544 551	allergy
T47	Drug 560 569	ibuprofen
T48	Scope 525 543	known or suspected
R14	Has_scope Arg1:T46 Arg2:T48	
R15	AND Arg1:T46 Arg2:T47	
T49	Condition 571 592	anaphylactic reaction
T50	Drug 601 645	Nonsteroidal anti-inflammatory drugs (NSAID)
R16	AND Arg1:T49 Arg2:T50	
T51	Temporal 647 653	active
T52	Qualifier 657 666	recurrent
T53	Qualifier 667 674	stomach
T54	Condition 697 705	bleeding
T55	Qualifier 678 686	duodenal
T56	Condition 687 693	ulcera
*	OR T56 T54
*	OR T55 T53
T57	Scope 687 705	ulcera or bleeding
T58	Scope 667 686	stomach or duodenal
*	OR T52 T51
T59	Scope 647 666	active or recurrent
R17	Has_scope Arg1:T57 Arg2:T58	
R18	Has_scope Arg1:T57 Arg2:T59	
T60	Condition 707 719;729 742	severe liver insufficiency
T61	Condition 707 713;723 742	severe renal insufficiency
T62	Condition 744 771	inflammatory bowel syndrome
T63	Condition 777 786	pregnancy
T64	Observation 787 800	breastfeeding
*	OR T63 T64 T61 T60 T49 T46 T57 T62
T65	Scope 525 800	known or suspected allergy against ibuprofen, anaphylactic reaction against Nonsteroidal anti-inflammatory drugs (NSAID), active or recurrent stomach or duodenal ulcera or bleeding, severe liver or renal insufficiency, inflammatory bowel syndrome, and pregnancy/breastfeeding
T66	Scope 489 523	contraindication against ibuprofen
R19	Subsumes Arg1:T66 Arg2:T65	
T67	Condition 803 812	pregnancy
T68	Observation 817 831	breast feeding
*	OR T67 T68
